| Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer LB Saltz, JV Cox, C Blanke, LS Rosen, L Fehrenbacher, MJ Moore, ... New England Journal of Medicine 343 (13), 905-914, 2000 | 3920 | 2000 |
| Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a … PM Hoff, R Ansari, G Batist, J Cox, W Kocha, M Kuperminc, J Maroun, ... Journal of Clinical Oncology 19 (8), 2282-2292, 2001 | 1536 | 2001 |
| Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase … ML Rothenberg, JV Cox, C Butts, M Navarro, YJ Bang, R Goel, S Gollins, ... Annals of Oncology 19 (10), 1720-1726, 2008 | 269 | 2008 |
| Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer TH Cartwright, A Cohn, JA Varkey, YM Chen, TP Szatrowski, JV Cox, ... Journal of clinical oncology 20 (1), 160-164, 2002 | 267 | 2002 |
| A multicenter, phase II trial of weekly irinotecan (CPT‐11) in patients with previously treated colorectal carcinoma ML Rothenberg, JV Cox, RF DeVore, JD Hainsworth, R Pazdur, SE Rivkin, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1999 | 239 | 1999 |
| Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease JV Cox, E Steane, G Cunningham, EP Frenkel Archives of internal medicine 148 (11), 2485-2489, 1988 | 186 | 1988 |
| The frequency of anemia and iron deficiency in the runner. EP Balaban, JV Cox, P Snell, RH Vaughan, EP Frenkel Medicine and science in sports and exercise 21 (6), 643-648, 1989 | 121 | 1989 |
| A phase III trial of Xeloda (capecitabine) in previously untreated advanced/metastatic colorectal cancer. JV Cox Proc Am Soc Clin Oncol 18, 265a, 1999 | 101 | 1999 |
| Principles of safe practice using an oncology EHR system for chemotherapy ordering, preparation, and administration, part 1 of 2 LN Shulman, RS Miller, EP Ambinder, PP Yu, JV Cox Journal of oncology practice 4 (4), 203, 2008 | 57 | 2008 |
| Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach SJC Lee, MA Clark, JV Cox, BM Needles, C Seigel, BA Balasubramanian Journal of oncology practice 12 (11), 1029-1038, 2016 | 54 | 2016 |
| Disaster, Divine Judgment, and Original Sin J Cox, G Finau, R Kant, J Tarai, J Titifanue The Contemporary Pacific 30 (2), 380-411, 2018 | 52 | 2018 |
| Evaluation of bone marrow iron stores in anemia associated with chronic disease: a comparative study of serum and red cell ferritin EP Balaban, RG Sheehan, SE Demian, JV Cox, EP Frenkel American journal of hematology 42 (2), 177-181, 1993 | 51 | 1993 |
| Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU) J Nemunaitis, J Cox, W Meyer, A Courtney, G Mues American journal of clinical oncology 20 (5), 527-529, 1997 | 43 | 1997 |
| Principles of safe practice using an oncology EHR system for chemotherapy ordering, preparation, and administration, part 2 of 2 LN Shulman, RS Miller, EP Ambinder, PP Yu, JV Cox Journal of oncology practice 4 (5), 254, 2008 | 40 | 2008 |
| Phase III trial of capecitabine + oxaliplatin (XELOX) vs. 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (FOLFOX4) as 2nd-line treatment for patients with … ML Rothenberg, M Navarro, C Butts, Y Bang, JV Cox, R Goel, S Gollins, ... Journal of Clinical Oncology 25 (18_suppl), 4031-4031, 2007 | 36 | 2007 |
| Payment for oncolytics in the United States: a history of buy and bill and proposals for reform BN Polite, JC Ward, JV Cox, RF Morton, J Hennessy, RD Page, RM Conti Journal of oncology practice 10 (6), 357, 2014 | 34 | 2014 |
| A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced … CD Blanke, J Shultz, J Cox, M Modiano, R Isaacs, B Kasimis, R Schilsky, ... Annals of oncology 13 (1), 87-91, 2002 | 32 | 2002 |
| Care coordination for complex cancer survivors in an integrated safety-net system: a study protocol SJC Lee, KK Jetelina, E Marks, E Shaw, K Oeffinger, D Cohen, NO Santini, ... BMC cancer 18, 1-10, 2018 | 28 | 2018 |
| Conceptual model for accrual to cancer clinical trials SJC Lee, CC Murphy, AM Geiger, DE Gerber, JV Cox, R Nair, CS Skinner Journal of Clinical Oncology 37 (23), 1993, 2019 | 27 | 2019 |
| The emergent middle classes in Timor-Leste and Melanesia: Conceptual issues and developmental significance J Barbara, J Cox, M Leach Canberra, ACT: State, Society and Governance in Melanesia (SSGM), Research …, 2015 | 23 | 2015 |
